SCHEMBL2056747

SCHEMBL2056747

ClC1=CC=CC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29035872 0.97
SCHEMBL28166931 0.69
Hydrochloric Acid SCHEMBL28176836 0.67
SCHEMBL28267747 0.67
SCHEMBL446759 0.67
SCHEMBL28840555 0.65
SCHEMBL2212441 0.65
SCHEMBL179728 0.65
Hydrochloric Acid SCHEMBL31508618 0.65
SCHEMBL366678 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113573723-B Synthetic neuromodulatory peptides 拉托科公司 2024-12-03 CN claimed
CN-119072304-A Neuroactive steroids for the treatment of CNS related disorders 萨奇治疗股份有限公司 2024-12-03 CN claimed
CN-119015253-A Water-medicine complex and preparation method thereof 天津医科大学第二医院 2024-11-26 CN claimed
CN-118370739-A Chlorine nitrogen gentle and controlled release preparation and preparation method thereof 湖南中南制药有限责任公司 2024-07-23 CN claimed
CN-110891562-B Lithium salts of N-substituted glycine compounds and uses thereof 心悦生医股份有限公司 2024-07-16 CN claimed
CN-117836284-A Methods of treating nerve agent-induced seizures 普罗尼拉斯公司 2024-04-05 CN claimed
CN-116087170-A Method for rapidly detecting four stimulants based on surface-enhanced Raman spectrum 厦门大学 2023-05-09 CN claimed
CN-110730781-B Tetrahydropyridopyrazine modulators of GPR6 武田药品工业株式会社 2023-05-05 CN claimed
EP-1931320-B1 MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME FLAMEL IRELAND LTD (IE) 2022-06-15 EP claimed
US-20090220611-A1 Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same FLAMEL TECHNOLOGIES, S.A. (FR) 2009-09-03 US claimed
EP-1931320-A2 MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL GALENIC FORM COMPRISING SAME Flamel Technologies (FR) 2008-06-18 EP claimed
WO-2007036671-A2 MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL GALENIC FORM COMPRISING SAME FLAMEL TECHNOLOGIES (FR) 2007-04-05 WO claimed
EP-1273301-B1 Pharmaceutical preparations based on active ingredients susceptible to illicit administration ALTERGON SA (CH) 2006-09-06 EP claimed
CN-122042350-A Rapid sample pretreatment device and method for paper purification and application of rapid sample pretreatment device and method in mass spectrometry 南京警察学院 2026-05-15 CN disclosed
CN-120154690-A Traditional Chinese medicine essential oil composition for preventing and/or treating insomnia and preparation method and application thereof 上海安好合医药开发有限公司 2025-06-17 CN disclosed
CN-115667235-B Compositions and methods for treating disorders ameliorated by muscarinic receptor activation 卡鲁娜治疗学有限公司 2025-06-17 CN disclosed
US-20040180088-A1 Gastric retention controlled drug delivery system SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2004-09-16 US disclosed
CN-1520286-A Gastric retention controlled drug delivery system ̫��ҽҩ��ҵ���޹�˾ 2004-08-11 CN disclosed
EP-1411901-A1 GASTRIC RETENTION CONTROLLED DRUG DELIVERY SYSTEM Sun Pharmaceuticals Industries Ltd. (IN) 2004-04-28 EP disclosed
WO-2003011255-A1 GASTRIC RETENTION CONTROLLED DRUG DELIVERY SYSTEM SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2003-02-13 WO disclosed